President Donald Trump says that he was likely to impose tariffs on pharmaceuticals as soon as the end of this month.

Indiana University officials say King will compete for the final time in Singapore after she announced her impending retirement last month. The 18-time World Champion will race the 50-meter ...

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.77 per share, beating the Zacks Consensus Estimate of $2.66 per share. This compares to earnings of $2.82 per share a year ago. These ...

The move reveals both the power of philanthropic groups to sway legislators and a split in the administration’s coalition.

Johnson & Johnson (JNJ) came out with quarterly earnings of $2.77 per share, beating the Zacks Consensus Estimate of $2.66 per share. This compares to earnings of $2.82 per share a year ago. These ...

Fort Wayne was No. 24 on LinkedIn’s list. LinkedIn called Fort Wayne a “city on the rise” because “a wave of new investments in data centers and tech infrastructure, coupled with affordable housing ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...

An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

Johnson & Johnson shows steady growth in Q2, driven by medtech and oncology, yet talc litigation overshadows. Click for my ...

Lilly, Johnson & Johnson, AbbVie, Pfizer and more pharma stocks shrug even amid Trump's fresh pharma tariff threats.

Illimis Therapeutics’ Series B round was led by Korean venture capital firm DSC Investment. Seoul-based Illimis Therapeutics has raised 58 billion won ($42 million) to fund its research into ...